Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New 20-Minute sore throat test could cut unnecessary antibiotics

NCT ID NCT06713642

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new rapid test called SPOTFIRE ST for people with sore throats in urgent care. The test uses PCR to find up to 13 different viruses and bacteria in about 20 minutes. Researchers wanted to see if doctors find it useful, how accurate it is, and whether patients and providers are satisfied with it. About 200 people took part, and the study is already completed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SPOTFIRE ST System (rapid PCR test device)
What this could lead to
If successful, this test could help doctors quickly identify the cause of a sore throat and prescribe antibiotics or antivirals more wisely.
What could go wrong
This is a small, completed study focused on test performance and satisfaction, not on patient health outcomes. The test may not change treatment decisions or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Dec 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 year and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Illness onset in the last 7 days, AND: * Ages 1-2 (12-35 months old) with fever or * Ages 3-17 with sore throat or * Any age with immunocompromising conditions or is on immunocompromising medications with sore throat or * Any age with comorbidities (e.g., respiratory, cardiovascular, metabolic, renal, etc.) with sore throat Exclusion Criteria: * Anatomic anomalies that would prohibit safely collecting a pharyngeal swab specimen * Symptom onset more than 7 days prior to arrival at urgent care * Patient is already on an antiviral medication or an antibiotic medication * Previous participation in the study * Unable to read and understand or refusal to sign the appropriate informed consent/assent forms * Refusal to provide their demographics, household information

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pharyngitis, infective are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UW Health Urgent Care Centers

    Madison, Wisconsin, 53717, United States